Profile of Nagoya University Hospital 2012

• Idea/Basic Decision
• Declaration Regarding Patients' Rights and Responsibilities
• Message From the Director

• Idea, Basic Decision, History
• Organization Chart of University Hospital
• Organization Chart of Administration Office
• Chronological List of Directors of University Hospital
• Established Date of Clinical Departments
• Clinical Departments
• Legal Authorization of Medical Services
• University Hospital Staff, Number of Staffs
• Number of Beds
• Patient Services in the University Hospital in 2011
• Clinical Indicator
• Access

Gastroenterological Surgery 1

Director NAGINO, Masato (Professor)   7W · 13E

Experienced staff do their utmost to treat diseases, mainly tumors

Digestive Surgery 1 provides medical care mainly for tumors in the gastrointestinal tract including stomach, duodenum, small intestine, and large intestine and liver, biliary tract (gallbladder and bile duct), and pancreas.

Medical Care System

A total of 28 surgeons with eight years or more of experience provide medical care. In the outpatient clinic, 10 surgeons with special expertise provide medical care three times a week (Monday, Wednesday, and Friday). In the inpatient department, at least two surgeons mainly provide medical care for each patient, but the treatment strategy and clinical course are always discussed with all members in our department.

Target Disease

We perform preoperative diagnosis, surgical therapy, perioperative management, postoperative chemotherapy, and therapy for recurrent cancer. We treat diseases such as hepatobiliary and pancreatic malignant tumor, chronic pancreatitis, benign biliary tract disease (such as gallstones), esophageal tumor, stomach tumor, large intestine / colorectal tumor, and pelvic tumor.

Strong Fields

We are confident in performing difficult surgery such as hepatopancreatoduodenectomy, hepatectomy with combined vascular resection for far-advanced biliary cancer and pelvic exenteration, and thoracolaparotomic esophagectomy. Especially, our department has the best treatment results for hilar cholangiocarcinoma regardless of whether in or outside of Japan. Recently we have also actively conducted non-invasive surgeries, such as laparoscopic liver resection, laparoscopic pancreatic resection, and single incision laparoscopic cholecystectomy, as well as robot-assisted surgeries for colorectal cancer using the da Vinci Surgical System.

Clinical Results

The total number of surgeries in 2011 was 671. Of those, hepatectomy for biliary cancer: 68; other hepatectomies: 37 (of those, 17 are laparoscopic surgery); laparoscopic cholecystectomy: 25 (of those, 14 are single incision type); pancreaticoduodenectomy: 26; distal pancreatectomy: 12 (of those, 4 are laparoscopic surgery); surgery for esophageal cancer: 30; other esophageal surgery: 5; gastric cancer: 48 (of those, 9 are laparoscopic surgery); surgery for colon cancer: 68 (of those, 32 are laparoscopic surgery); surgery for rectal cancer: 69 (of those, 22 are laparoscopic surgery, 4 are robot-assisted surgery, and 14 are pelvic exenteration). The number of resections for hilar cholangiocarcinoma is the largest in Japan.

Advanced Medicine and Research

Robot-assisted surgery for colorectal cancer using the da Vinci Surgical System. A phase III comparative study in patients with resected cholangiocarcinoma is conducted comparing the group receiving postoperative adjuvant chemotherapy with gemcitabine and the surgery alone group; a phase II clinical study of postoperative adjuvant chemotherapy with TS-1 in patients who underwent resection for liver metastasis resulting from colorectal cancer.

Website of the Department
http://www.med.nagoya-u.ac.jp/tumor/